Australia, Oct. 21 -- CELLTRION Inc., owns the trademark (2683877) for 'PEBLYSMA' till July 6, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of cancer; medicines for human purposes.]
Type of Mark: Word
Date of Acceptance: Aug. 13
Registration Advertised: Oct. 20
For further details contact JIDAM IP LAW FIRM.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2683877.
Disclaimer: Curated by HT Syndication....